Head-to-head · WeighScore
CoreAge Rx vs Vita Bella
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 64.9/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | Vita Bella |
|---|---|---|
| WeighScore | 89.5/100 | 64.9/100 |
| Grade | B+ | C |
| Site position | #1 | #258 |
| Semaglutide | Product page from $79/mo; navigation $99. Confirm selected quote. | Not disclosed |
| Tirzepatide | From $129/mo advertised; confirm selected charge, supply and renewal. | $159/mo (2.5 mg dose, plus a separate fee, compounded) |
| Coverage | US only; therapy-specific state restrictions apply | 46 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Site position #258 · C
Strengths
- Offers both compounded semaglutide (from $109/mo) and tirzepatide (from $159/mo) at member pricing, with supplies and a B-6 add-in included
- Clearly disclosed legal entity, Vita Bella Health, LLC (Nevada)
- Broad access: care published for 46 states plus Washington, D.C., and HSA cards are accepted
- Fully remote telehealth with video provider consults and quarterly provider check-ins included in the membership
- Medications dispensed by US FDA-inspected compounding pharmacies; ondansetron for nausea provided at no extra charge
What to consider
- Advertised $109-$159 medication prices require a separate $129/mo membership plus a one-time $99 consult, pushing true cost to ~$238-288/mo
- Three-month minimum commitment before it renews month-to-month; no refunds on medications and all sales are final
- Compounding pharmacy partners are not named anywhere on the site — a transparency gap
- Compounded semaglutide and tirzepatide are not FDA-approved; only the dispensing pharmacies are described as FDA-inspected
- Disputes are subject to binding arbitration with a class-action waiver, governed by Nevada law (Las Vegas jurisdiction)
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.